These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (“Jazz” or the “Company”) and Chimerix (Nasdaq: CMRX) (“Chimerix”), today announced the companies have entered into a definitive agreement for Jazz to acquire ...

The FDA is expected to decide on treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine.

Fully human intranasal foralumab shows promise in treating Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS.

New types of wearables and devices can record bodily data or simulate the senses without needing to meet stringent med-tech ...

Q4 2024 Earnings Conference Call March 5, 2025 5:00 PM ETCompany ParticipantsKirsten Newquist - Chief Executive ...

Humana Inc. (the "company") announced today the completion of its public offering of $1.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $750 million of ...